This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1992 Mar;68(3):293-302.

doi: 10.1093/bja/68.3.293.

Pharmacology, mechanisms of action and uses of selective phosphodiesterase inhibitors

J R Skoyles, K M Sherry

PMID: 1547054
DOI: 10.1093/bja/68.3.293

Free article

Review

Pharmacology, mechanisms of action and uses of selective phosphodiesterase inhibitors

J R Skoyles et al. Br J Anaesth. 1992 Mar.

Free article

. 1992 Mar;68(3):293-302.

doi: 10.1093/bja/68.3.293.

Authors

J R Skoyles, K M Sherry

PMID: 1547054
DOI: 10.1093/bja/68.3.293

No abstract available

PubMed Disclaimer

Similar articles

[Treatment of cardiac insufficiency: inotropic stimulation or relief of cardiac load? (Report 1)].
Mareev VIu. Mareev VIu. Kardiologiia. 1993;33(12):6-14. Kardiologiia. 1993. PMID: 7910868 Review. Russian. No abstract available.
Enoximone in heart failure: mechanisms of action.
Chatterjee K. Chatterjee K. Br J Clin Pract Suppl. 1988 Dec;64:19-25. Br J Clin Pract Suppl. 1988. PMID: 2978496 Review. No abstract available.
New positive inotropic agents.
Jafri SM, Bristol JA. Jafri SM, et al. Henry Ford Hosp Med J. 1986;34(3):188-92. Henry Ford Hosp Med J. 1986. PMID: 3542907 Review. No abstract available.
Clinical pharmacology of inodilators.
Dei Cas L, Metra M, Visioli O. Dei Cas L, et al. J Cardiovasc Pharmacol. 1989;14 Suppl 8:S60-71. J Cardiovasc Pharmacol. 1989. PMID: 2483442 Review.
Metabolic effects of phosphodiesterase III inhibitors: another reason to promote their use?
Simkova V, Radermacher P, Barth E. Simkova V, et al. Crit Care. 2007;11(3):139. doi: 10.1186/cc5924. Crit Care. 2007. PMID: 17572916 Free PMC article.

See all similar articles

Cited by

Population pharmacokinetics of olprinone in healthy male volunteers.
Kunisawa T, Kasai H, Suda M, Yoshimura M, Sugawara A, Izumi Y, Iida T, Kurosawa A, Iwasaki H. Kunisawa T, et al. Clin Pharmacol. 2014 Mar 4;6:43-50. doi: 10.2147/CPAA.S50626. eCollection 2014. Clin Pharmacol. 2014. PMID: 24623995 Free PMC article.
The role of phosphodiesterase 3 in endotoxin-induced acute kidney injury.
Choi WI, Kwon KY, Seo JW, Beagle J, Quinn DA, Hales CA. Choi WI, et al. BMC Infect Dis. 2009 Jun 1;9:80. doi: 10.1186/1471-2334-9-80. BMC Infect Dis. 2009. PMID: 19486524 Free PMC article.
Pretreatment with a Phosphodiesterase-3 Inhibitor, Milrinone, Reduces Hepatic Ischemia-Reperfusion Injury, Minimizing Pericentral Zone-Based Liver and Small Intestinal Injury in Rats.
Nakanuma S, Tajima H, Takamura H, Sakai S, Gabata R, Okazaki M, Shinbashi H, Ohbatake Y, Makino I, Hayashi H, Miyashita T, Fushida S, Ohta T. Nakanuma S, et al. Ann Transplant. 2020 Jul 14;25:e922306. doi: 10.12659/AOT.922306. Ann Transplant. 2020. PMID: 32661218 Free PMC article.
The effect of milrinone on the right ventricular function in patients with reduced right ventricular function undergoing off-pump coronary artery bypass graft surgery.
Lee JH, Oh YJ, Shim YH, Hong YW, Yi G, Kwak YL. Lee JH, et al. J Korean Med Sci. 2006 Oct;21(5):854-8. doi: 10.3346/jkms.2006.21.5.854. J Korean Med Sci. 2006. PMID: 17043419 Free PMC article. Clinical Trial.
Amrinone, in combination with norepinephrine, is an effective first-line drug for difficult separation from cardiopulmonary bypass.
Hardy JF, Searle N, Roy M, Perrault J. Hardy JF, et al. Can J Anaesth. 1993 Jun;40(6):495-501. doi: 10.1007/BF03009729. Can J Anaesth. 1993. PMID: 8403112 Clinical Trial.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science